1st October 2024, London  – Genpax, a leader in pathogen genomics, is proud to announce a strategic partnership with IQVIA, a global provider of advanced health analytics, technology solutions, and clinical research services. Together, the two organizations aim to accelerate the fight against antimicrobial resistance (AMR) and other infectious diseases by leveraging cutting-edge genomics and data analytics solutions. Through this collaboration, Genpax will provide cutting-edge genomics to...

Presented by Karolina Jackowska at the ESCMID Global Conference in Barcelona, 2024 Download the High Resolution PDF below:

Genpax, a life science startup focused on transforming healthcare in detecting, tracing, and mitigating the spread of bacterial pathogens, has been announced as a winner by the IET for their 2023 Excellence and Innovation Awards. The Awards celebrate the most pioneering engineering and technology innovations across 16 sectors, from energy and sustainability to manufacturing and healthcare. Chosen by a panel of expert judges, Genpax won the Health Technology award for their revolutionary...